ARROTEX Pharmaceuticals announced last week that it is taking over the sponsorship of the Ordine (morphine) oral liquid products after Mundipharma stated it discontinued supply last year.
The TGA said the shortage of these products will continue in the short term, and Arrotex is anticipating a return to normal supply later this year.
Meanwhile, the TGA added that overseas-registered products are available and can be used until the supply of Ordine recommences.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 24
